Skip to main content
. 2018 Jan 11;13(1):e0186582. doi: 10.1371/journal.pone.0186582

Table 3. Dietary intake of macro-nutrients and DR.

Author, year Association Study Design Quality Dietary Factor Sample Size DR outcome type Confounders adjusted for Statistical methods Main Findings
Dietary Fats / lipids
Mono-Unsaturated Fatty Acids (MUFA)
Alcubierre, 2016 Protective Case-Control 10 MUFA Case: 146
Ctrl: 148
Prevalence Age, gender, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic BP, HDL cholesterol & diabetes treatment Multivariable Logistic Regression High MUFA consumption vs Low MUFA consumption, OR: 0.42 (0.18–0.97)
Cundiff, 2005 Risk Prospective 8 MUFA 1412 Progression Energy Intake Spearman Correlation MUFA in %/kcal against DR progression rate, r = 0.12 (p = 0.001)
Roy, 2010 NS Prospective 9 MUFA 469 Progression & Incidence Total caloric intake, total fat, sat fat, oleic acid, linoleic acid, protein, fiber, cholesterol & sodium intakes Multivariable Logistic Regression No significant associations with DR (Data not reported)
Sasaki, 2015 NS Cross Sectional 10 MUFA 379 Prevalence Age, gender, HBA1C, mean arterial pressure & diabetes duration Multivariable logistic regression models Per 10 energy-adjusted g/d increase, OR: 1.19 (0.74–1.92)
Roy, 1989 NS Cross-Sectional 5 MUFA 34 Prevalence Energy Intake t-test No significant associations with DR (Data not reported)
Poly-Unsaturated Fatty Acids (PUFA)
Sala-Vila, 2016 Protective Prospective 9 PUFA (LCw3) 3482 Incidence Age, gender, BMI, intervention group, yeasr after diagnosis of diabetes, use of insulin, use of oral hypoglycemic agents, smoking, systolic BP, hypertension, physical activity, adherence to meddiet. Cox Proportional Hazard Model >500mg/d Vs <500mg/d, HR: 0.52 (0.31–0.88)
Sasaki, 2015 Protective for well controlled diabetics Cross Sectional 10 PUFA 379 Prevalence Age, gender, HBA1C, mean arterial pressure & diabetes duration Multivariable logistic regression models All subjects:
Per 10 energy-adjusted g/d increase, OR: 0.67 (0.37–1.20)
Well controlled Diabetics:
Per 10 energy-adjusted g/d increase, OR: 0.18 (0.06–0.59)
Cundiff, 2005 Risk Prospective 8 PUFA 1412 Progression Energy Intake Spearman Correlation PUFA in %/kcal against DR progression rate, r = 0.09 (r = 0.004)
Roy, 2010 NS Prospective 9 PUFA 469 Progression & Incidence Total caloric intake, total fat, sat fat, oleic acid, linoleic acid, protein, fiber, cholesterol & sodium intakes Multivariable Logistic Regression No significant associations with DR (Data not reported)
Alcubierre, 2016 NS Case-Control 10 PUFA Case: 146
Ctrl: 148
Prevalence Age, gender, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic BP, HDL cholesterol & diabetes treatment Multivariable Logistic Regression High PUFA consumption vs Low MUFA consumption, OR: 0.99 (0.69–1.41)
Roy, 1989 NS Cross-Sectional 5 PUFA 34 Prevalence Energy Intake t-test No significant associations with DR (Data not reported)
Oleic Acid
Alcubierre, 2016 Protective Case-Control 10 Oleic Acid Case: 146
Ctrl: 148
Prevalence Age, gender, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic BP, HDL cholesterol & diabetes treatment Multivariable Logistic Regression High Intake Tertile (T3) vs Lowest Intake Tertile (T1), OR: 0.37 (0.16–0.85)
Roy, 2010 NS Prospective 9 Oleic Acid 469 Progression & Incidence Total caloric intake, total fat, sat fat, oleic acid, linoleic acid, protein, fiber, cholesterol & sodium intakes Multivariable Logistic Regression No Significant associations with DR (Data not reported)
Interventional Studies
Houtsmuller, 1979 Protective Interventional High Bias Unsaturated Fats 96 Progression Matched for gender Saturated Fat Diet Vs Unsaturated Fat Diet
Males (n = 52, 26 on each diet)
P<0.001
Females (n = 44, 22 on each diet)
P<0.025
Howard-williams, 1985 NS Interventional High Bias PUFA 149 Incidence Matched for age, sex & BMI Persons on modified fat diet (PUFA: saturated fat ratio, 0.3) vs persons on low carb diet (PUFA: Saturated fat ratio, 0.9)
All patients (n = 149)
No difference between two groups (chi-squared, p = 0.69)
Dietary compliers (n = 58)
No difference between two groups (chi-squared, p = 0.13)
Carbohydrates
Cundiff, 2005 Protective Prospective 8 Carbohydrates 1412 Progression Energy Intake Spearman Correlation Carbohydrates in %/kcal against DR progression rate, r = -0.11 (p<0.001)
Roy, 1989 Protective Cross-Sectional 5 Carbohydrates 34 Prevalence Energy Intake t-test Persons without retinopathy vs Persons with retinopathy (p<0.05)
Horikawa, 2017 NS Prospective 10 Carbohydrates 978 Incidence and Progression Age, sex, BMI, HbA1C, Diabetes Duration, systolic BP, LDL-cholesterol, HDL-cholesterol, triglycerides, treatment by insulin, treatment by antihypertensive agents, treatment by lipid-lowering agents, current smoker, alcohol intake, energy intake & physical activity Multivariable Cox Regression Models Highest Intake Tertile (T3) vs lowest Intake Tertile (T1), HR: 1.00 (0.72–1.38)
Roy, 2010 NS Prospective 9 Carbohydrates 469 Progression & Incidence Total caloric intake, total fat, sat fat, oleic acid, linoleic acid, protein, fiber, cholesterol & sodium intakes Multivariable Logistic Regression No significant associations with DR (Data not reported)
Alcubierre, 2016 NS Case-Control 10 Carbohydrates Case: 146
Ctrl: 148
Prevalence Age, gender, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic BP, HDL cholesterol & diabetes treatment Multivariable Logistic Regression High Intake Tertile (T3) vs lowest intake tertile (T1), OR: 1.18 (0.45–3.09)
Sasaki, 2015 NS Cross Sectional 8 Carbohydrates 379 Prevalence Energy Intake Chi-Squared No significant associations with DR (data not reported)
Protein
Cundiff, 2005 Protective Prospective 8 Protein 1412 Progression Energy Intake Spearman Correlation Protein in %/kcal against DR progression rate, r = -0.6 (p = 0.0188)
Roy, 1989 Risk Cross-Sectional 5 Protein 34 Prevalence Energy Intake t-test Persons without retinopathy vs Persons with retinopathy (p<0.02)
Roy, 2010 NS Prospective 9 Protein 469 Progression & Incidence Total caloric intake, total fat, sat fat, oleic acid, linoleic acid, protein, fiber, cholesterol & sodium intakes Multivariable Logistic Regression No Significant associations with DR (Data not reported)
Alcubierre, 2016 NS Case-Control 10 Protein Case: 146
Ctrl: 148
Prevalence Age, gender, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic BP, HDL cholesterol & diabetes treatment Multivariable Logistic Regression Highest protein intake tertile (T3) vs lowest protein intake tertile (T1), OR: 1.24 (0.49–3.16)
Sasaki, 2015 NS Cross Sectional 8 Protein 379 Prevalence Energy Intake Chi-Squared No Significant associations with DR (Data not reported)